BRAFv600E mutation is not a positive predictor for distant metastasis in sporadic papillary thyroid carcinoma

被引:8
|
作者
Jing Fan-jing [1 ]
Liang Jun [1 ]
Liang Zhi-yong [2 ]
Meng Chao [1 ]
Long Wen [3 ]
Li Xiao-yi [4 ]
Lin Yan-song [3 ]
机构
[1] Qingdao Univ, Qingdao Med Coll, Affiliated Hosp, Dept Oncol, Qingdao 266003, Shandong, Peoples R China
[2] Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China
[3] Peking Union Med Coll Hosp, Dept Nucl Med, Beijing 100730, Peoples R China
[4] Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China
基金
中国国家自然科学基金;
关键词
papillary thyroid carcinoma; B-RAF; neoplasm metastasis; vascular endothelial growth factor; BRAF MUTATION; CLINICAL-IMPLICATIONS; PROGNOSTIC-FACTORS; CANCER; SURVIVAL; OUTCOMES; EPIDEMIOLOGY; VEGF;
D O I
10.3760/cma.j.issn.0366-6999.20122032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background BRAF(v600E) mutation is correlated with local aggressive clinicopathological features in papillary thyroid carcinoma; yet the relationship between this genetic variation and distant papillary thyroid carcinoma metastasis was unclear. This study aimed to investigate whether BRAF(v600E) is predictive for distant metastasis in the Chinese population. Methods One hundred and seven patients with papillary thyroid carcinoma were enrolled in this study, including 43 patients with distant metastasis and 64 patients without. Quantitative real-time polymerase chain reaction was used to detect BRAF(v600E) mutation, while immunohistochemistry was performed to detect vascular endothelial growth factor (VEGF) expression. The associations between distant metastasis and BRAF(v600E) mutation, and VEGF expression as well as local clinicopathological factors were determined. Results A total of 28.6% of the patients in the distant metastasis group harbored BRAF(v600E) mutation, which was significantly lower than in the without distant metastasis group (68.8%, P < 0.001). BRAF(v600E) mutation was negatively correlated with positive VEGF expression (P=0.001). Furthermore, 52.2% of the patients with distant metastasis exhibited VEGF expression, compared with 25.0% of those without. Higher levels of VEGF expression were also observed in the distant metastasis group. Tumor size, extra-thyroid invasion, and BRAF(v600E) mutation were independent predictors for distant metastasis according to multivariate analysis (odds ratios were 2.8, 12.4, and 0.3; 95% C/ 1.483-5.334, and 2.950-52.407, 0.100-0.890; P=0.002, 0.001, and 0.030, respectively). BRAF(v600E) mutation was negatively correlated with distant metastasis in adult subgroup analysis (P=0.005) but was not an independent parameter. Conclusions BRAF(v600E) mutation is predictive for distant metastasis in papillary thyroid carcinoma but not positively. VEGF may be involved in the pathogenesis of distant metastasis.
引用
收藏
页码:3013 / 3018
页数:6
相关论文
共 50 条
  • [31] BRAFV600E mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic
    V. Sykorova
    S. Dvorakova
    A. Ryska
    J. Vcelak
    E. Vaclavikova
    J. Laco
    D. Kodetova
    R. Kodet
    A. Cibula
    J. Duskova
    A. Hlobilkova
    J. Astl
    D. Vesely
    J. Betka
    J. Hoch
    S. Smutny
    J. Cap
    P. Vlcek
    Z. Novak
    B. Bendlova
    Journal of Endocrinological Investigation, 2010, 33 : 318 - 324
  • [32] Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAFV600E Mutation
    Lee, Seung Eun
    Hwang, Tae Sook
    Choi, Yoon-La
    Kim, Wook Youn
    Han, Hye Seung
    Lim, So Dug
    Kim, Wan-Seop
    Yoo, Young Bum
    Kim, Suk Kyeong
    THYROID, 2017, 27 (06) : 802 - 810
  • [33] Clinicopathological significance of BRAFV600E mutation in Uyghur Chinese patients with papillary thyroid carcinoma
    Wen, Hao
    Aizezi, Abudureyinnu
    Yasenjiang, Maimaiti
    Sailike, Magaoweiya
    Wufuer, Yimaer
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (01): : 200 - 207
  • [34] Accuracy and Reproducibility of Histologic Features Predictive of BRAFV600E Mutation in Papillary Thyroid Carcinoma
    Virk, R. K.
    Finkelstein, A.
    Prasad, A.
    Hui, P.
    Chhieng, D.
    Theoharis, C.
    Gibson, J.
    Roman, S.
    Prasad, M.
    LABORATORY INVESTIGATION, 2012, 92 : 150A - 151A
  • [35] Morphology predicts BRAFV600E mutation in papillary thyroid carcinoma: an interobserver reproducibility study
    Renu K. Virk
    Constantine G. A. Theoharis
    Avinash Prasad
    David Chhieng
    Manju L. Prasad
    Virchows Archiv, 2014, 464 : 435 - 442
  • [36] Detection of Circulating BRAFV600E in Patients with Papillary Thyroid Carcinoma
    Lubitz, Carrie C.
    Parangi, Sareh
    Holm, Tammy M.
    Bernasconi, M. Jordana
    Schalck, Aislyn P.
    Suh, Hyunsuk
    Economopoulos, Konstantinos P.
    Gunda, Viswanath
    Donovan, Samuel. E.
    Sadow, Peter M.
    Wirth, Lori J.
    Sullivan, Ryan J.
    Panka, David J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (01): : 100 - 108
  • [37] Utilization of a MAB for BRAFV600E detection in papillary thyroid carcinoma
    Bullock, M.
    O'Neill, C.
    Chou, A.
    Clarkson, A.
    Dodds, T.
    Toon, C.
    Sywak, M.
    Sidhu, S. B.
    Delbridge, L. W.
    Robinson, B. G.
    Learoyd, D. L.
    Capper, D.
    von Deimling, A.
    Clifton-Bligh, R. J.
    Gill, A. J.
    ENDOCRINE-RELATED CANCER, 2012, 19 (06) : 779 - 784
  • [38] BRAFV600E Mutation: Has It a Role in Cervical Lymph Node Metastasis of Papillary Thyroid Cancer?
    Kurtulmus, Neslihan
    Ertas, Burak
    Saglican, Yesim
    Kaya, Hakan
    Ince, Umit
    Duren, Mete
    EUROPEAN THYROID JOURNAL, 2016, 5 (03) : 195 - 200
  • [39] The Presence of Typical “BRAFV600E-Like” Atypia in Papillary Thyroid Carcinoma is Highly Specific for the Presence of the BRAFV600E Mutation
    John Turchini
    Loretta Sioson
    Adele Clarkson
    Amy Sheen
    Leigh Delbridge
    Anthony Glover
    Mark Sywak
    Stan Sidhu
    Anthony J. Gill
    Endocrine Pathology, 2023, 34 : 112 - 118
  • [40] Histopathologic Characteristics of Thyroid Tumors Positive for BRAFV600E Mutation
    Nugent, W.
    Coyne, C.
    Nikiforova, M. N.
    Nikiforov, Y. E.
    LABORATORY INVESTIGATION, 2012, 92 : 148A - 149A